CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL, AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED [***].Lease Agreement • August 10th, 2022 • Haemonetics Corp • Surgical & medical instruments & apparatus • Baja California
SECOND AMENDMENT TO LEASE AGREEMENT SEGUNDO CONVENIO MODIFICATORIO AL CONTRATO DE ARRENDAMIENTO This Second Amendment to Lease Agreement (this “Second Amendment”) is entered into as of this 17th day of June, 2022, by and between Mrs. Blanca Estela Colunga Santelices (“Mrs. Colunga”) and Haemonetics Mexico Manufacturing, S. de R.L. de C.V. (“Haemonetics”). Este Segundo Convenio Modificatorio al Contrato de Arrendamiento (el "Segundo Convenio Modificatorio"), se celebra este día 17 de junio del 2022, por y entre la Sra. Blanca Estela Colunga Santelices (la "Sra. Colunga") y Haemonetics Mexico Manufacturing, S. de R.L. de C.V. (“Haemonetics"). WHEREAS, Mrs. Colunga and Haemonetics are parties to a certain Lease dated December 3, 2007 together with any and all amendments, modifications, extensions, etc. (collectively, the “Lease Agreement”) entered into with respect to the land and buildings, located at Calle Colinas No. 11731, Parque Industrial El Florido, Seccion Colinas, Delegacion la P
June 14, 2022 Michelle Basil c/o Haemonetics Corporation Boston, MA 02110 RE: Executive Vice President and General Counsel Retention and Transition Agreement Dear Michelle:Retention and Transition Agreement • August 10th, 2022 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts
This Retention and Transition Agreement (this “Agreement”) sets forth the understanding between you and Haemonetics Corporation (the “Company”) regarding your continued employment as Executive Vice President and General Counsel of the Company and your planned resignation from the Company and transition. On behalf of the Board of Directors of the Company, I want to thank you for your willingness to provide continued service as Executive Vice President and General Counsel in order to ensure a seamless and successful transition to the next Executive Vice President and General Counsel of the Company.
